counter free hit invisible
Kembali ke Beranda

Is Now the Right Time to Invest in Eli Lilly Stock?

16 Juni 2026
5 menit baca
Redaksi musik.proAktif.id
Is Now the Right Time to Invest in Eli Lilly Stock?

Eli Lilly is once again a trillion-dollar company by market cap. The stock has risen modestly by 5% this year, but its five-year returns are impressive, exceeding 400%. The company has become a significant player in the GLP-1 weight loss market, and investors have been eager to purchase its shares.

However, the stock's valuation may be a cause for concern. With a price-to-earnings ratio of 40, it's not exactly cheap. The question remains: is Eli Lilly stock still a good investment today, or is it better to wait for a potential pullback in its price?

When investing, it's essential to focus on the long-term prospects of a company. Eli Lilly's growth prospects look promising, given the diversity of its operations and the growth-oriented nature of its management.

The company is in the early stages of growing its GLP-1 products, Mounjaro and Zepbound. While they're already generating billions in sales, they may still generate much more in the future. Additionally, Eli Lilly has been acquiring other healthcare companies to expand its operations, such as Orna Therapeutics, which develops RNA therapies for cancer and autoimmune diseases.

Eli Lilly's financial resources enable it to continue investing in its future, making it a compelling long-term investment. In the trailing 12 months, its net income has totaled $25.3 billion, a significant increase from a couple of years ago, when its profit was nearly one-fifth of that total.

For a top growth stock, you may have to pay a premium. But in return, you get an investment in a top company with promising long-term growth opportunities. That's what Eli Lilly's stock represents today. It isn't cheap, but it can still be a good buy at its current valuation, given its terrific upside.

In the short term, the stock may fluctuate due to market conditions and broader healthcare reform concerns. But over the long run, the business is likely to do well and continue to grow strongly. As long as you're committed to owning the stock for the long term, this can be an excellent investment to add to your portfolio today.

Ringkasan

Eli Lilly's stock has reached a trillion-dollar market cap, with impressive returns over the past five years. But is it still a good buy at its current valuation?

Bagikan Artikel

Salin Tautan

Berita Terbaru